Goon D, Klaassen C D
Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City 66103.
Toxicol Appl Pharmacol. 1989 Aug;100(1):41-50. doi: 10.1016/0041-008x(89)90090-2.
Previous studies have shown that the disposition of cadmium (Cd) following oral administration is dosage dependent and may possibly be due to dosage-dependent intestinal absorption of Cd. Though extensively studied, the precise nature of Cd absorption by the intestine remains unclear. Similarly, the role of metallothionein (MT) in the intestinal absorption of Cd remains equivocal. The present study was designed (1) to characterize the intestinal absorption of Cd in the rat, and (2) to determine the role of MT in intestinal Cd absorption. The study has been conducted with an isolated intestinal loop preparation in situ, which allows direct measurement of intestinal absorption under nearly physiological conditions. Under urethane-induced anesthesia. Cd (0.1, 10, 100, 1000, or 10,000 micrograms/kg) was injected intraluminally into the isolated intestinal loop in situ and all mesenteric venous (portal) blood exiting from the loop was collected for 90 min. Absorption of Cd into the portal circulation was low at all dosages studied. The percentage of the dosage absorbed ranged from 0.09% at the 0.1 microgram/kg dosage to 3.4% at the 10,000 micrograms/kg dosage. At low dosages (0.1 and 10 micrograms/kg), little difference was noted in the fractional absorption of Cd (0.09 and 0.14% of the dosage, respectively). However, the fractional absorption of Cd was 10-fold greater in rats administered 100 micrograms Cd/kg (1.1% of the dosage). Administration of higher dosages of Cd (1000 and 10,000 micrograms/kg) further increased the percentage of the dosage absorbed (1.8 and 3.4%, respectively). To evaluate the role of MT in the intestinal absorption of Cd. rats were subcutaneously injected with zinc (Zn) for 4 days (30 mg/kg/day) and the absorption of an intermediate dosage of Cd (100 micrograms/kg) was subsequently assessed in situ. Zn pretreatment increased the endogenous concentration of MT in the intestine 25-fold. Following intraluminal administration. 93% of Cd in intestinal cytosol of Zn-treated rats was bound to MT whereas 40% of the cytosolic Cd was bound to MT in saline-treated (control) rats. Moreover, the amount of Cd in intestinal cytosol was 2-fold greater in Zn-treated rats than in control rats. However, the intestinal absorption of Cd in rats pretreated with Zn demonstrated no difference from that in saline-treated rats. These results indicate that the intestinal absorption of Cd is dosage independent at low dosages of Cd (less than 10 micrograms/kg) and dosage dependent at high dosages (greater than 10 micrograms/kg). Furthermore, saturation of intestinal MT is not a major determinant of the observed dosage-dependent absorption of Cd.
以往的研究表明,口服镉(Cd)后的处置具有剂量依赖性,这可能是由于肠道对镉的吸收存在剂量依赖性。尽管已进行了广泛研究,但肠道对镉吸收的确切性质仍不清楚。同样,金属硫蛋白(MT)在肠道对镉的吸收中的作用也仍不明确。本研究旨在:(1)描述大鼠肠道对镉的吸收特征,以及(2)确定MT在肠道镉吸收中的作用。该研究采用了原位分离肠袢制备方法,这使得在近乎生理条件下能够直接测量肠道吸收情况。在氨基甲酸乙酯诱导的麻醉下,将镉(0.1、10、100、1000或10000微克/千克)经腔内注射到原位分离的肠袢中,并收集从肠袢流出的所有肠系膜静脉(门静脉)血液,持续90分钟。在所研究的所有剂量下,镉进入门静脉循环的吸收都很低。吸收剂量的百分比范围从0.1微克/千克剂量时的0.09%到10000微克/千克剂量时的3.4%。在低剂量(0.1和10微克/千克)时,镉的分数吸收几乎没有差异(分别为剂量的0.09%和0.14%)。然而,给予100微克镉/千克的大鼠中镉的分数吸收增加了10倍(剂量的1.1%)。给予更高剂量的镉(1000和10000微克/千克)进一步增加了吸收剂量的百分比(分别为1.8%和3.4%)。为了评估MT在肠道镉吸收中的作用,给大鼠皮下注射锌(Zn)4天(30毫克/千克/天),随后原位评估中等剂量镉(100微克/千克)的吸收情况。锌预处理使肠道中MT的内源性浓度增加了25倍。腔内给药后,锌处理大鼠的肠道细胞质中93%的镉与MT结合,而生理盐水处理(对照)大鼠中40%的细胞质镉与MT结合。此外,锌处理大鼠肠道细胞质中的镉含量比对照大鼠高2倍。然而,锌预处理大鼠的肠道镉吸收与生理盐水处理大鼠相比没有差异。这些结果表明,在低剂量镉(小于10微克/千克)时,肠道对镉的吸收与剂量无关,而在高剂量(大于10微克/千克)时与剂量有关。此外,肠道MT的饱和不是观察到的镉剂量依赖性吸收的主要决定因素。